(Q71321836)

English

Phase II trial of taxol in patients with adenocarcinoma of the upper gastrointestinal tract (UGIT). The Eastern Cooperative Oncology group (ECOG) results

scientific article published on 01 January 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8729950%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

Phase II trial of taxol in patients with adenocarcinoma of the upper gastrointestinal tract (UGIT). The Eastern Cooperative Oncology group (ECOG) results (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8729950%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

phase II clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Peter H. Wiernik

3

object named as

P H Wiernik

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8729950%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

author name string

A I Einzig

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8729950%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

S Lipsitz

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8729950%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

A B Benson

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8729950%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

publication date

1 January 1995

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8729950%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

Investigational New Drugs

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8729950%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8729950%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8729950%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

223-227

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8729950%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

https://scigraph.springernature.com/pub.10.1007/bf00873804

0 references

Hypersensitivity reactions from taxol

1 reference

https://pubmed.ncbi.nlm.nih.gov/8729950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8729950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II trial of taxol in metastatic melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8729950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/8729950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of taxol in patients with malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8729950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results

1 reference

https://pubmed.ncbi.nlm.nih.gov/8729950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8729950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study and long-term follow-up of patients treated with taxol for advanced ovarian adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8729950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms

1 reference

https://pubmed.ncbi.nlm.nih.gov/8729950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00873804

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8729950%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8729950%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71321836&oldid=1753827407"